Home nerve stimulation for bladder problems after spinal cord injury
Tests tibial nerve stimulation at home for neurogenic bladder in people with spinal cord injury.
Key facts
- Who runs it
- The University of Texas Health Science Center, Houston
- Where
- Houston, United StatesSee the site
- Trial code
- Registry title
- Home Neuromodulation for Neurogenic Bladder Management in Spinal Cord Injury
- Status
- Recruiting
- People taking part
- 21 people, planned
- Started
- 7 May 2026
- Expected to end
- 1 Sept 2028
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- iTNS
- Sham iTNS
- Record updated
- 11 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a long-term spinal cord injury and bladder problems caused by it. It tests a tibial nerve stimulation device used at home.
- Age
- 18 Years to 75 Years
- Sex
- All sexes can join
- Disease stage
- Spinal cord injury that is not getting worse, present for more than 1 year, at level T9 or above.
- Earlier treatment
- Must be on a stable dose of overactive bladder (OAB) medicines for at least 3 months. No Botulinum toxin-A injections in the bladder within 6 months before joining. No restorative bladder surgery such as augmentation cystoplasty.
- Biomarker or test result
- Must feel stimulation through the skin (tTNS) and have both big toes bend with it. Must pass the tTNS skills checklist. Must be able to have an MRI.
Main reasons for not taking part
- Active cancer of the urinary or genital organs
- Other brain or nerve disorders, or nerve damage in the limbs (peripheral neuropathy)
- Pregnancy or planning a pregnancy
- Taking blood thinners, for treatment or prevention
- Advanced blood vessel disease in the limbs, or past intolerance to electrical stimulation
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Non-progressive chronic (>1 year) SCI
- Neurologic level of injury T9 and above
- Stable over active bladder (OAB) medications (≥3 months)
- No contraindication to MRI (per MRI Safety Questionnaire)
- English or Spanish speaking
- Tolerate and be able to evoke toe flexion bilaterally with transcutaneous tibial nerve stimulation (tTNS) (self or assisted)
- Pass the tTNS competency checklist to perform or direct performance of tTNS
Who cannot take part
- Restorative bladder surgery such as augmentation cystoplasty
- History of other central nervous system disorder (CNS) disorders and/or peripheral neuropathy
- Advanced peripheral vascular disease (gangrene, amputation, etc.)
- History of intolerance to electrical stimulation, particularly of the leg
- Ongoing/active genitourinary oncologic diagnoses
- Pregnancy or planning to become pregnant
- Lower Motor Neuron bladder
- Botulinum toxin-A injections in the bladder within 6 months of trial enrolment (injection in other sites is allowed)
- Anticoagulation treatment or prophylaxis
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
This trial is currently available in United States.
- The University of Texas Health Science Center at HoustonHouston, United StatesContact: Argyrios Stampas, MDTaking people
About the trial
What the trial wants to find out
The purpose of this study is to determine the safety and efficacy of Injectrode Tibial Nerve Stimulation for bladder function in people with spinal cord injury.
The 3 groups in the trial
- Bilateral iTNSTreatment being tested
participants will receive one active tibial nerve stimulation (TNS) device and both legs will receive active stimulation
Treatment: iTNS
- Unilateral iTNSExisting treatment, for comparison
participants will receive one active and one sham tibial nerve stimulation (TNS) device. The treatment will only be delivered to the leg with the active device.
Treatment: iTNS and Sham iTNS
- Sham iTNSSham treatment, for comparison
participants will receive one one sham tibial nerve stimulation (TNS) device for bilateral use.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Home Neuromodulation for Neurogenic Bladder Management in Spinal Cord Injury: A Hybrid Implementation-Efficacy Trial
- Plain-language title
- Home nerve stimulation for bladder problems after spinal cord injuryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT07264868, who can take part
- Record updated
- 11 May 2026